U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated ...

Utah health officials and medical providers are celebrating a 41% decrease in opioid prescriptions in an effort to reduce ...

The new treatment targets gut hormone GLP-1 but also mimics amylin, a hormone released by the pancreas that suppresses hunger ...

Novo Nordisk shares were 9.5% higher after the pharmaceutical giant said an experimental weight-loss shot showed patients ...

Texas Instruments falls after the chip maker’s first-quarter earnings forecast misses estimates, and Boeing declines after ...

Amycretin could give Novo a buzzy product in a newly competitive obesity market. It works similarly to existing GLP-1 ...

KEY TAKEAWAYS Novo Nordisk's U.S.-listed shares are surging 9% Friday morning after the Danish drugmaker reported early stage ...

British authorities arrested two drug traffickers belonging to a larger organized crime group, thanks largely to intelligence ...

It's the start of a new year, and that makes now the perfect time to load up on stocks that could boost your portfolio in ...

(AP Photo/Gregory Bull) Paraphernalia supporting President Donald Trump is displayed at a post on the floor of the New York ...

The U.S. Food and Drug Administration ( FDA) has approved the use of a nasal spray as a standalone treatment for major depressive disorder, offering a new option for those struggling with ...